Shandong Weigao Orthopedic Device Company
Weihai
About Shandong Weigao Orthopedic Device Company
Shandong Weigao Orthopedic Device Company (“Weigao Ortho”) is a medical device company in China specializing in the research and development, production and sale of spine, trauma and joint orthopedic implants. They have a leading position in the fast-growing orthopedic implant market in China, and they are the largest domestic orthopedic implant producer in China and the fifth largest among all orthopedic implant producers in China in terms of sales revenue in each of 2012 and 2013. Shandong Weigao Orthopedic Device Company is also one of the first domestic orthopedic implant producers in China that target the mid to premium orthopedic implant markets. Weigao Ortho sell products primarily under ‘‘Wego Ortho” brand, which is their major brand that enjoys a wide market recognition in mid to premium orthopedic implant, they also sell mid-range and economy segment products under “Yahua” and “JianliBangde” brands. Weigao Ortho has established an extensive network of distributors in China. Their distributors together have an extensive coverage of Class III hospitals, a traditional market for higher end products. Their extensive network of distributors allows us to take advantage of the well-established sales channels and logistic infrastructures as well as abundant capital and customer resources of their distributors. Leveraging the knowledge and skills of their research and development professionals, Weigao Ortho successfully developed and commercially launched a number of orthopedic implant products. They were also the registered owner of number of patents.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 10,001+
- Estimated revenue: $100K – $500K
- Website: wegortho.com
- Phone: 86(0)631-5788927
Industries & Categories
Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/shandong-weigao-orthopedic-device-company-950568 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.